Direct Oral Anticoagulants for the Treatment of Cancer-Associated Venous Thromboembolism: A Latin American Perspective

Venous thromboembolism (VTE) is a leading cause of morbidity and mortality in patients with cancer. On the basis of results from randomized controlled trials, direct oral anticoagulants (DOACs) are now recommended for the treatment of cancer-associated VTE. The decision to use a DOAC requires consid...

Descripción completa

Detalles Bibliográficos
Autores principales: Athanazio, Rodrigo Abensur, Ceresetto, José Manuel, Marfil Rivera, Luis Javier, Cesarman-Maus, Gabriela, Galvez, Kenny, Marques, Marcos Arêas, Tabares, Aldo Hugo, Ortiz Santacruz, Carlos Alberto, Santini, Fernando Costa, Corrales, Luis, Cohen, Alexander T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918974/
https://www.ncbi.nlm.nih.gov/pubmed/35261295
http://dx.doi.org/10.1177/10760296221082988

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918974/
https://www.ncbi.nlm.nih.gov/pubmed/35261295
http://dx.doi.org/10.1177/10760296221082988

Ejemplares similares